The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations.
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Genentech/Roche; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
Huamao Mark Lin
Employment - Takeda
Stock and Other Ownership Interests - Change Healthcare (I)
Travel, Accommodations, Expenses - Takeda
 
Jin-Liern Hong
Employment - Millennium
 
Yu Yin
Employment - Millennium
 
Shu Jin
Employment - Millennium
 
Jianchang Lin
Employment - Millennium
 
Minal Mehta
Employment - Millennium
 
Danny Nguyen
No Relationships to Disclose
 
Joel W. Neal
Honoraria - Biomedical Learning Institute; Clinical Care Options; CME Matters; Medscape; MJH Life Sciences; Peerview; Prime Oncology; Projects in Knowledge; Research to Practice; Rockpointe CME
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Calithera Biosciences; Exelixis; Genentech/Roche; Iovance Biotherapeutics; Jounce Therapeutics; Lilly; Natera; Regeneron; Takeda
Research Funding - AbbVie (Inst); Adaptimmune (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Up To Date - Royalties